Dietary nutrition supplement for regulating glycometabolism based on green tea cell wall polysaccharide and tea polyphenol and application of dietary nutrition supplement

By combining green tea cell wall polysaccharides with tea polyphenols in different proportions, the optimal ratio was selected and dietary nutritional supplements were prepared, which solved the problem of unclear interaction mechanism between tea polyphenols and tea polysaccharides, and achieved the metabolism of glycolipids Regulating and lowering blood sugar effects have the potential for application in patients with hyperglycemia and diabetes.

CN118985908APending Publication Date: 2024-11-22SHANGHAI JIAOTONG UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411114091.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

There are few reports on the interaction between tea polyphenols and tea polysaccharides in the prior art, and lack of in-depth research has affected the development of the medicinal value of tea in lowering blood sugar and regulating sugar metabolism.

Method used

By combining the purified green tea cell wall polysaccharides with tea polyphenols in different proportions, the inhibitory activity of sugar metabolism enzymes in vitro and the effect of lowering blood sugar in vivo, the optimal compound ratio of lowering blood sugar activity was screened, and a green tea cell wall was prepared based on green tea cell wall Dietary nutritional supplements for polysaccharides and tea polyphenols to regulate sugar metabolism.

Benefits of technology

It has achieved regulation of glycolipid metabolism, reduced oxidative stress, improved the body's inflammatory response, significantly inhibited enzymes related to sugar metabolism, and had good lowering blood sugar effects, especially in the group of patients with hyperglycemia and diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118985908A_ABST
    Figure CN118985908A_ABST
Patent Text Reader

Abstract

The invention relates to a dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol and application of the dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol, the active ingredients of the dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol comprise green tea cell wall polysaccharide and tea polyphenol, the mass ratio of the green tea cell wall polysaccharide to the tea polyphenol is (1: 3)-(3: 1). The invention further discloses application of the dietary nutrition supplement or a preparation containing the dietary nutrition supplement in preparation of drugs and health care products for regulating glycolipid metabolism. Compared with the prior art, the dietary nutrition supplement provided by the invention can regulate glycolipid metabolism, reduce oxidative stress and improve body inflammatory response, and has a good application prospect in hyperglycemia / diabetes patient groups.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of food technology, and in particular to a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols and an application thereof. Background Art

[0002] Tea polyphenols (TP) have been found to have a variety of health functions and pharmacological effects, and can be used as an ideal natural medicine and natural non-toxic antioxidant. The antioxidant effect of tea polyphenols can effectively prevent or inhibit the activity of oxidases and interrupt the chain reaction in the oxidation process, thereby showing a strong ability to resist oxidation and scavenge free radicals, thereby protecting cells from oxidative damage, making tea polyphenols have anti-cancer, anti-mutation, anti-tumor, hypoglycemic and other biological activities. Tea polyphenols can play a hypoglycemic role by affecting pathways such as sugar metabolism and insulin resistance, and can be used as a potential functional food to regulate the health of the body. Tea polysaccharides (TPS) are widely used in the treatment of diabetes in traditional Chinese and Japanese medicine. TPS has a strong inhibitory effect on the sugar metabolism-related enzyme system in the human body and its hypoglycemic activity is concentration-dependent, which provides a reference for its reasonable dosage as a potential drug. These findings expand the potential application scope of natural plant polysaccharides in the treatment of diabetes and provide important clues and research directions for the development of new diabetes treatment drugs.

[0003] Tea can be regarded as a "compound" agent with multiple active ingredients, which are usually combined with tea polysaccharides and appear in crude TPS. Tea polysaccharides can better regulate glucose and lipid metabolism disorders and insulin resistance in the liver, while black tea polyphenols improve serum and liver lipid levels, antioxidant capacity, visceral fat weight and fecal fatty acid content. Coarse old green tea and black tea polysaccharides have good hypoglycemic effects both in vivo and in vitro, and can significantly inhibit the activity of α-glucosidase and β-amylase and delay glucose absorption; Liubao tea can regulate the intestinal flora in the hyperglycemic mouse model and activate the liver PI3K-Akt signaling pathway to relieve hyperglycemia, insulin resistance and related metabolic disorders. Polyphenols and polysaccharides have been proven to have synergistic hypoglycemic and lipid-control effects in in vitro experiments and animal levels. At present, there are few reports on the interaction between tea polyphenols and tea polysaccharides. The biological activity of tea polysaccharide-tea polyphenol complexes is closely related to their interaction. By exploring the structure-activity relationship of tea polysaccharide-tea polyphenol complexes, guidance can be provided for the development of highly active functional foods. Therefore, future research needs to further explore the mechanism of action of active ingredients in tea to provide a scientific basis for the medicinal value of tea and the development of new drugs. Summary of the invention

[0004] The purpose of the present invention is to solve the above problems and to provide a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols and its application. The purified green tea cell wall polysaccharides and tea polyphenols are compounded in different proportions to explore the in vitro sugar metabolism enzyme inhibition activity and structural differences of green tea cell wall polysaccharides / tea polyphenols compounds in different proportions and the in vivo hypoglycemic effect on hyperglycemic mice. Finally, the compounding ratio with the best hypoglycemic activity is screened out, which provides an important reference for the research and development of blood sugar-lowering functional products.

[0005] The purpose of the present invention is achieved through the following technical solutions:

[0006] The first object of the present invention is to provide a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols, the dietary nutritional supplement comprising an active ingredient; the active ingredient comprises purified green tea cell wall polysaccharides and tea polyphenols; in the active ingredient, the mass ratio of the purified green tea cell wall polysaccharides to the tea polyphenols is 1:3 to 3:1.

[0007] Furthermore, the preparation method of the dietary nutritional supplement comprises the following steps: self-assembling and compounding the purified green tea cell wall polysaccharide with tea polyphenols to improve the solubility of the green tea cell wall polysaccharide.

[0008] Furthermore, the preparation method of the dietary nutritional supplement specifically includes the following steps: weighing purified green tea cell wall polysaccharides (p4M-TPS) and tea polyphenols (TP), adding ultrapure water to dissolve and mix and stir evenly, filtering the mixed solution through a 0.22 μm filter membrane, and freeze-drying the filtrate to obtain a purified green tea cell wall polysaccharide and tea polyphenols complex, named p4M-TPS-TP.

[0009] Furthermore, the preparation method of the dietary nutritional supplement specifically includes the following steps: weighing purified green tea cell wall polysaccharides (p4M-TPS) and tea polyphenols (TP) into a conical flask, adding ultrapure water to dissolve, mixing and stirring evenly according to different mass concentration ratios (p4 M-TPS / TP is 1:1, 1:2, 2:1, 1:3 and 3:1), filtering the mixed solution through a 0.22 μm filter membrane, and freeze-drying the filtrate to obtain a purified green tea cell wall polysaccharide and tea polyphenols complex (p4 M-TPS and TP complex), named p4 M-TPS-TP.

[0010] Furthermore, the dietary supplement also includes pharmaceutically acceptable excipients.

[0011] Furthermore, the auxiliary material is selected from one or more of starch, dextrin, cellulose, cellulose derivatives or oligosaccharides.

[0012] Further, the dietary nutritional supplement comprises the following raw materials in parts by weight: 1 part of purified green tea cell wall polysaccharide, 2 parts of tea polyphenols, 0.2-0.8 parts of stevioside C, 0.2-0.8 parts of vitamin D2, and 0.2-0.8 parts of leucine. Further, the dietary nutritional supplement is in the form of a tablet, capsule, granule, granule or pill.

[0013] Furthermore, the active ingredient of the dietary nutritional supplement is a compound based on green tea cell wall polysaccharides and tea polyphenols, and the preparation method of the compound based on green tea cell wall polysaccharides and tea polyphenols is:

[0014] The purified tea cell wall polysaccharide and polyphenol are self-assembled and compounded to improve the solubility of the purified tea cell wall polysaccharide. Specifically, the following steps are included: p4M-TPS and TP are weighed in a conical flask, ultrapure water is added to dissolve, and mixed and stirred evenly according to different mass concentration ratios (p4 M-TPS / TP is 1:1, 1:2, 2:1, 1:3 and 3:1), and the mixed solution is filtered through a 0.22μm filter membrane, and the filtrate is freeze-dried to obtain a p4M-TPS and TP compound, which is named p4 M-TPS-TP.

[0015] Furthermore, the method for preparing the purified green tea cell wall polysaccharide comprises the following steps:

[0016] Green tea is sequentially extracted with water, cyclohexanediaminetetraacetic acid, sodium carbonate and sodium hydroxide solutions of different concentrations, and then purified green tea cell wall polysaccharides are obtained through impurity removal, dialysis and freeze-drying.

[0017] Furthermore, the method for preparing the purified green tea cell wall polysaccharide specifically comprises the following steps:

[0018] (1) After grinding green tea leaves, pass through an 80-mesh sieve to obtain tea powder, add ultrapure water at a solid-liquid ratio of 1:20 to the tea powder, extract at 37°C for 2 hours, then centrifuge (5000 rpm, 10 min) to obtain the supernatant, repeat the above steps with the precipitate until the sugar content is no longer detected in the supernatant, combine the supernatants and use a 7000Da dialysis bag for 72 hours, the supernatant is the extract, retain the tea residue and dry it to obtain dried tea residue for subsequent steps; add ethanol at a volume ratio of extract: ethanol = 1:3, let stand at 4°C overnight, then centrifuge (5000 rpm, 10 min) to collect the precipitate; redissolve the precipitate with water and centrifuge to obtain the supernatant, repeat 3 times, combine the supernatants, and obtain water-extracted tea polysaccharides (W-TPS) after freeze-drying (48 hours).

[0019] (2) adding 70% ethanol to the dried tea residue obtained in step (1) at a solid-liquid ratio of 1:10, shaking on a shaker at room temperature for 12 hours, centrifuging the solution to collect the precipitate, repeatedly washing the precipitate with 70% ethanol for 3-5 times, washing it once with anhydrous ethanol, and then placing the precipitate in a fume hood to dry to obtain alcohol-insoluble tea residue; adding Tris-maleic acid buffer at a solid-liquid ratio of 1:10, wherein the concentration of the Tris-maleic acid buffer is 20 mmol / L, and the pH of the Tris-maleic acid buffer is 6.9, and adding 2 mmol / L The ratio of CaCl2 and amylase, amylase and alcohol-insoluble tea residue is 20 mg amylase / 5 g tea residue, shake on a shaker at 37°C for 4 hours to remove starch, obtain tea residue with starch removed, wash the tea residue with starch removed 3-5 times, centrifuge to obtain the precipitate and place it in a fume hood to dry, add cyclohexanediaminetetraacetic acid solution to the dried tea residue with starch removed at a solid-liquid ratio of 1:10, the concentration of the cyclohexanediaminetetraacetic acid solution is 50 mmol / L, the pH of the cyclohexanediaminetetraacetic acid solution is 6.5, shake on a shaker at 37°C for 12 hours, then centrifuge and dialyze the supernatant for 72 hours using a 7000Da dialysis bag to obtain a precipitate and an extract, wash the precipitate 3-5 times, place it in a fume hood to dry, and obtain tea residue extracted with CDTA; after the dialysis is completed, add ethanol at a ratio of extract: ethanol = 1:3, let it stand overnight at 4°C, and then centrifuge to obtain the precipitate. The precipitate was re-dissolved in water and then centrifuged to obtain the supernatant. This process was repeated three times. The supernatants were combined and freeze-dried to obtain CDTA-extracted tea polysaccharides (C-TPS).

[0020] (3) The tea residue obtained in step (2) after CDTA extraction is added to a saturated sodium carbonate solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 is added to the solution to protect the polysaccharide, and the extraction is performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant is dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract, and the precipitate is washed 3-5 times and then dried to obtain the tea residue after saturated sodium carbonate extraction; ethanol is added at a volume ratio of extract: ethanol = 1:3, and the mixture is allowed to stand at 4°C overnight, and then centrifuged to obtain the precipitate; the precipitate is redissolved in water and then centrifuged to obtain the supernatant, and the process is repeated 3 times. The supernatants are combined and freeze-dried to obtain sodium carbonate-extracted polysaccharides (Na2CO3-extracted tea polysaccharides, N-TPS).

[0021] (4) The tea residue obtained in step (3) after extraction with saturated sodium carbonate was added to 1 mol / L NaOH solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 was added to the solution to protect the polysaccharide, and the extraction was performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant was dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract, and the precipitate was washed 3-5 times and then dried to obtain the tea residue extracted with 1 mol / L NaOH solution; ethanol was added at a volume ratio of extract: ethanol = 1:3, and the mixture was allowed to stand at 4°C overnight, and the precipitate was collected by centrifugation; the precipitate was redissolved with water and then centrifuged to obtain the supernatant, and the process was repeated 3 times. The supernatants were combined and freeze-dried to obtain polysaccharides extracted with 1 mol / L NaOH solution (1M NaOH-extracted tea polysaccharides, 1M-TPS).

[0022] (5) The tea residue obtained in step (4) after extraction with 1 mol / L NaOH solution is added to 4 mol / L NaOH solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 is added to the solution, and the extraction is performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant is dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract; after rotary evaporation and concentration, ethanol is added at a volume ratio of 1:3 between the water extract and ethanol, and the mixture is allowed to stand at 4°C overnight, and the precipitate is obtained by centrifugation; the precipitate is redissolved in water and centrifuged to obtain the supernatant, and the process is repeated 3 times. The supernatants are combined and freeze-dried to obtain polysaccharides extracted with 4 mol / L NaOH solution (4M NaOH-extracted tea polysaccharides, 4M-TPS).

[0023] (6) When phosphate buffered saline (PBS) was used as the eluent, a large amount of tea polysaccharides were eluted. However, when a concentration gradient sodium chloride solution was subsequently used for elution, very little polysaccharide elution was detected. Therefore, the fractions eluted and collected under PBS conditions were selected, combined, concentrated and freeze-dried to obtain purified tea polysaccharides, named p4M-TPS.

[0024] Further, step (6) comprises the following steps: dissolving the polysaccharide extracted by 4 mol / L NaOH solution in phosphate buffer solution PBS (pH=6.8, 0.02 mol / L) until the concentration of the polysaccharide solution is 50 mg / mL, filtering through a 0.22 μm filter membrane, washing the gel column equipped with DEAE-Sepharose Fast Flow gel filler to equilibrium and then loading the sample, slowly and evenly dripping the polysaccharide solution into the anion gel column (2.5 cm×60 cm) with a dropper, turning on the liquid flow switch after stabilization, and gradient eluting with PBS buffer solution containing 0, 0.1, 0.2, 0.3, 0.4, and 0.5 mol / L NaCl in sequence, and switching the concentration gradient after elution until no sugar is detected. The experiment uses an automatic collector to collect the eluate (2 mL / min, 2 min / tube), and uses the phenol-sulfuric acid method to determine the total sugar content of the collected liquid, and draws the elution curve with its OD value at 490 nm as the ordinate and the number of tubes as the abscissa. The eluates under the single peak were combined, concentrated, and dialyzed for 72 hours using a 3500Da dialysis bag, and freeze-dried to obtain purified tea polysaccharides, named p4M-TPS. The second object of the present invention is to provide a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols for use in the preparation of medicines or health products for regulating sugar and lipid metabolism, reducing oxidative stress, and improving inflammatory response of the body.

[0025] Furthermore, the instructions of the medicine or health product state that the intake of the compound of green tea cell wall polysaccharide and tea polyphenol is controlled to be 350-450 mg / d.

[0026] Compared with the prior art, the beneficial effects of the present invention are embodied in the following aspects:

[0027] 1) The present invention proposes a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols and its application. The provided dietary nutritional supplement can regulate sugar and lipid metabolism, reduce oxidative stress, and improve the body's inflammatory response, and has good application prospects in the hyperglycemia / diabetes patient group;

[0028] 2) The present invention proposes a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols and its application. The purified green tea cell wall polysaccharides are compounded with tea polyphenols in different proportions to explore the in vitro sugar metabolism enzyme inhibition activity and structural differences of green tea cell wall polysaccharides / tea polyphenols compounds in different proportions and the in vivo hypoglycemic effect on hyperglycemic mice, and finally screen out the compound ratio with the best hypoglycemic activity.

[0029] 3) The present invention proposes a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols and its application. The polysaccharides extracted by sequential extraction with 4M sodium hydroxide are purified to obtain purified tea cell wall polysaccharides including neutral sugars, uronic acid and reducing sugars. The combination of tea polysaccharides and tea polyphenols has stronger inhibitory activity on sugar metabolism-related enzymes (α-glucosidase, α-amylase and sucrase) than any single component. When the ratio of p4M-TPS / TP is 1:1, 1:2 and 2:1, the inhibitory effect of the combination is obvious, and the IC of α-glucosidase is 0.04477 for α-glucosidase. 50 The values ​​were 6.970, 6.493 and 5.673 μg / mL, respectively, and the IC 50 The values ​​were 2.934, 4.458 and 5.057 mg / mL, respectively, and the IC 50 The values ​​were 4.003, 2.029 and 2.692 mg / mL respectively. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 The present invention is a schematic flow diagram of a method for preparing a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols.

[0031] Figure 2 The inhibitory activities of the p4M-TPS / TP combination at different ratios on α-glucosidase (A), α-amylase (B) and sucrase (C) (Note: different superscript letters indicate significant differences among the groups, p<0.05).

[0032] Figure 3 Physiological indicators of mice: body weight (A), body weight change (B), fasting blood glucose (C), fasting blood glucose change (D); glucose tolerance (OGTT) and insulin tolerance (ITT) of mice after 6 weeks of intervention, including OGTT (E), area under the OGTT curve (F), ITT (G), and area under the ITT curve (H); serum glucose and lipid metabolism indicators TC (I), TG (J), LDL-C (K), and HDL-C (L) of mice after intervention (Note: * indicates statistically significant difference compared with MC group, *, p<0.05; **, p<0.01; ***, p<0.001; different superscript letters indicate significant difference between groups, p<0.05).

[0033] Figure 4 Pathological analysis of mouse colon tissue (200x).

[0034] Figure 5The expression of key proteins of TGR5 / GLP-1 pathway in pancreatic tissue of mice after intervention, including TGR5 (A), cAMP (B), PKA (C), CREB (D), PC1 / 3 (E), and GLP-1 (F); Western blot of key proteins of pancreatic TGR5 / GLP-1 pathway (Note: *The difference was statistically significant compared with the MC group. *, p<0.05; **, p<0.01; ***, p<0.001).

[0035] Figure 6 The expression of key proteins of TGR5 / GLP-1 pathway in colon tissue of mice after intervention, including TGR5 (A), cAMP (B), PKA (C), CREB (D), PC1 / 3 (E), GLP-1 (F); Western blot of key proteins of TGR5 / GLP-1 pathway in mouse colon (G). (Note: * indicates that there is a statistically significant difference compared with the MC group. *, p<0.05; **, p<0.01; ***, p<0.001). DETAILED DESCRIPTION

[0036] The present invention is described in detail below in conjunction with specific embodiments, but is by no means intended to limit the present invention. Features such as preparation methods, materials, structures or composition ratios not explicitly described in this technical solution are considered to be common technical features disclosed in the prior art.

[0037] The green tea is Yichang stir-fried green tea.

[0038] The tea polyphenols are from Shanghai Yuanye Biotechnology Co., Ltd.

[0039] The α-glucosidase solution was purchased from Shanghai MacLean Biochemical Technology Co., Ltd.

[0040] The method for preparing the purified green tea cell wall polysaccharide specifically comprises the following steps:

[0041] (1) After grinding green tea leaves, pass through an 80-mesh sieve to obtain tea powder, add ultrapure water at a solid-liquid ratio of 1:20 to the tea powder, extract at 37°C for 2 hours, then centrifuge to obtain the supernatant, repeat the above steps for the precipitate to extract until the sugar content in the supernatant is no longer detected, combine the supernatants and use a 7000Da dialysis bag for 72 hours, the supernatant is the extract, retain the tea residue and dry it to obtain dried tea residue for subsequent steps; add ethanol at a volume ratio of extract: ethanol = 1:3, let stand at 4°C overnight, then centrifuge to collect the precipitate; redissolve the precipitate with water and centrifuge to obtain the supernatant, repeat 3 times, combine the supernatants, and freeze-dry to obtain water-extracted tea polysaccharides (W-TPS).

[0042] (2) adding 70% ethanol to the dried tea residue obtained in step (1) at a solid-liquid ratio of 1:10, shaking on a shaker at room temperature for 12 hours, centrifuging the solution to collect the precipitate, repeatedly washing the precipitate with 70% ethanol for 3-5 times, washing it once with anhydrous ethanol, and then placing the precipitate in a fume hood to dry to obtain alcohol-insoluble tea residue; adding Tris-maleic acid buffer at a solid-liquid ratio of 1:10, wherein the concentration of the Tris-maleic acid buffer is 20 mmol / L, and the pH of the Tris-maleic acid buffer is 6.9, and adding 2 mmol / L The ratio of CaCl2 and amylase, amylase and alcohol-insoluble tea residue is 20 mg amylase / 5 g tea residue, shake on a shaker at 37°C for 4 hours to remove starch, obtain tea residue with starch removed, wash the tea residue with starch removed 3-5 times, centrifuge to obtain the precipitate and place it in a fume hood to dry, add cyclohexanediaminetetraacetic acid solution to the dried tea residue with starch removed at a solid-liquid ratio of 1:10, the concentration of the cyclohexanediaminetetraacetic acid solution is 50 mmol / L, the pH of the cyclohexanediaminetetraacetic acid solution is 6.5, shake on a shaker at 37°C for 12 hours, then centrifuge and dialyze the supernatant for 72 hours using a 7000Da dialysis bag to obtain a precipitate and an extract, wash the precipitate 3-5 times, place it in a fume hood to dry, and obtain tea residue extracted with CDTA; after the dialysis is completed, add ethanol at a ratio of extract: ethanol = 1:3, let it stand overnight at 4°C, and then centrifuge to obtain the precipitate. The precipitate was re-dissolved in water and then centrifuged to obtain the supernatant. This process was repeated three times. The supernatants were combined and freeze-dried to obtain CDTA-extracted tea polysaccharides (C-TPS).

[0043] (3) The tea residue obtained in step (2) after CDTA extraction is added to a saturated sodium carbonate solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 is added to the solution to protect the polysaccharide, and the extraction is performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant is dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract, and the precipitate is washed 3-5 times and then dried to obtain the tea residue after saturated sodium carbonate extraction; ethanol is added at a volume ratio of extract: ethanol = 1:3, and the mixture is allowed to stand at 4°C overnight, and then centrifuged to obtain the precipitate; the precipitate is redissolved in water and then centrifuged to obtain the supernatant, and the process is repeated 3 times. The supernatants are combined and freeze-dried to obtain sodium carbonate-extracted polysaccharides (Na2CO3-extracted tea polysaccharides, N-TPS).

[0044] (4) The tea residue obtained in step (3) after extraction with saturated sodium carbonate was added to 1 mol / L NaOH solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 was added to the solution to protect the polysaccharide, and the extraction was performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant was dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract, and the precipitate was washed 3-5 times and then dried to obtain the tea residue extracted with 1 mol / L NaOH solution; ethanol was added at a volume ratio of extract: ethanol = 1:3, and the mixture was allowed to stand at 4°C overnight, and the precipitate was collected by centrifugation; the precipitate was redissolved with water and then centrifuged to obtain the supernatant, and the process was repeated 3 times. The supernatants were combined and freeze-dried to obtain polysaccharides extracted with 1 mol / L NaOH solution (1M NaOH-extracted tea polysaccharides, 1M-TPS).

[0045] (5) The tea residue obtained in step (4) after extraction with 1 mol / L NaOH solution is added to 4 mol / L NaOH solution at a material-liquid ratio of 1:10, and 25 mmol / L NaBH4 is added to the solution, and the extraction is performed on a shaking table at 37°C for 12 hours. After centrifugation, the supernatant is dialyzed using a 7000Da dialysis bag for 72 hours to obtain a precipitate and an extract; after rotary evaporation and concentration, ethanol is added at a volume ratio of 1:3 between the water extract and ethanol, and the mixture is allowed to stand at 4°C overnight, and the precipitate is obtained by centrifugation; the precipitate is redissolved in water and centrifuged to obtain the supernatant, and the process is repeated 3 times. The supernatants are combined and freeze-dried to obtain polysaccharides extracted with 4 mol / L NaOH solution (4M NaOH-extracted tea polysaccharides, 4M-TPS).

[0046] (6) The polysaccharide extracted by 4 mol / L NaOH solution was dissolved in phosphate buffer solution PBS (pH=6.8, 0.02 mol / L) until the concentration of the polysaccharide solution was 50 mg / mL. After filtering through a 0.22 μm filter membrane, the gel column filled with DEAE-Sepharose FastFlow gel filler was rinsed to equilibrium and then loaded with the sample. The polysaccharide solution was slowly and evenly added to the anion gel column (2.5 cm×60 cm) with a dropper. After stabilization, the flow switch was turned on, and the PBS buffer solution containing 0, 0.1, 0.2, 0.3, 0.4, and 0.5 mol / L NaCl was used for gradient elution in turn. After elution until no sugar was detected, the concentration gradient was switched. The eluate was collected by an automatic collector (2 mL / min, 2 min / tube), and the total sugar content of the collected liquid was determined using the phenol-sulfuric acid method. The elution curve was drawn with its OD value at 490 nm as the ordinate and the number of tubes as the abscissa. The eluates under a single peak were combined, concentrated, and dialyzed for 72 h using a 3500Da dialysis bag. Purified tea polysaccharides were obtained after freeze-drying and named p4M-TPS.

[0047] Example 1

[0048] like Figure 1 As shown, this embodiment provides a method for preparing a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols, wherein tea cell wall polysaccharides and polyphenols are self-assembled and compounded.

[0049] 1) Compounding of green tea cell wall polysaccharides and tea polyphenols

[0050] The purified tea cell wall polysaccharide (p4M-TPS) and tea polyphenols (TP) are self-assembled and compounded. Specifically, the following steps are included: p4M-TPS and TP are weighed in a conical flask, and ultrapure water is added to dissolve them (the concentration of the compound is 0.5-500 μg / mL, see Figure 2 ), mixed and stirred evenly according to different mass concentration ratios (p4M-TPS / TP is 1:1, 1:2, 2:1, 1:3 and 3:1), the mixed solution was filtered through a 0.22 μm filter membrane, and the filtrate was freeze-dried for 48 h to obtain a complex of p4M-TPS and TP, named p4M-TPS-TP.

[0051] 2) Determination of the inhibitory activity of the compound on α-glucosidase

[0052] The α-glucosidase inhibitory activity of tea polysaccharides was determined by chromogenic method using an enzyme reader. The experimental groups were blank group Ab (no test solution and enzyme solution), control group Ac (no test solution), test solution group As, and test solution blank group Asb (no enzyme solution). Nitrophenyl-α-D-pyranoglucoside (PNPG) was used as the chromogenic substrate, and the entire experimental process was carried out in a 96-well plate. In the experiment, 60 μL of PBS phosphate buffer (67 mmol / L, pH=6.8), 20 μL of α-glucosidase solution (0.25 U / mL), and 20 μL of sample solution of different concentrations were added to the plate in sequence according to different groups (the concentration gradient of tea polysaccharide test solution was set to 0.1, 1, 10, 100, 1000 μg / mL). After low-speed oscillation, the plate was placed in a 37°C water bath for 10 min. Then, 20 μL of PNPG saturated solution was added to each well as a reaction substrate to start the enzyme reaction. After low-speed oscillation, the plate was placed in a 37°C water bath for 20 min for full reaction. After the reaction, 80 μL of Na2CO3 solution (0.2 mol / L) was quickly added to the system to terminate the catalytic reaction. After low-speed oscillation, the absorbance of each well was measured on the microplate reader, and the measurement wavelength was 405 nm. Finally, the inhibition rate of the sample on α-glucosidase was calculated according to the following formula:

[0053] I(%)-{[(Ac Ab)(As Asb)] / (As Asb)}×100%

[0054] 3) Determination of the inhibitory activity of the compound on α-amylase

[0055] The α-amylase inhibitory activity of tea polysaccharides was determined by 3,5-dinitrosalicylic acid method. The experimental groups were blank group Ab (no test solution and enzyme solution), control group Ac (no test solution), test solution group As, and test solution blank group Asb (no enzyme solution). This experimental method uses starch solution as a chromogenic substrate. In the experiment, phosphate buffer (67mmol / L, pH=6.8) was added to each stoppered graduated test tube in turn, followed by 50μL of the sample solution to be tested (the concentration gradient of the tea polysaccharide test solution was set to 0.05, 0.1, 0.5, 1, 5mg / mL) and 50μL of 2.5U / mL α-amylase (dissolved in PBS buffer, pH=6.8), the above mixture was mixed with a vortex oscillator and placed at 37.5℃ for 10min, then 100μL of 1% starch solution (dissolved in PBS buffer, pH=6.8) was added and mixed and placed at 37.5℃ for 10min. After the reaction was completed, 200μL of DNS solution was added and reacted under boiling water bath conditions for 5min, and then quickly placed in cold water to cool to room temperature to terminate the reaction. After oscillation, the absorbance was measured using a UV spectrophotometer, with PBS buffer as a blank, and the OD value was measured at 540nm after dilution. Finally, the inhibition rate of the sample on α-amylase was calculated according to the following formula:

[0056] I(%)={[(Ac-Ab)-(As-Asb)] / (Ac-Ab)}×100%

[0057] 4) Determination of the inhibitory activity of the compound on sucrase

[0058] The sucrase inhibitory activity of tea polysaccharide samples was determined according to the method described previously for determining the inhibitory activity of α-amylase. The experimental groups were divided into blank group Ab (no test solution and enzyme solution), control group Ac (no test solution), test solution group As, and test solution blank group Asb (no enzyme solution). The experimental method used sucrose solution as the substrate. In the experiment, PBS buffer (67mmol / L, pH=6.8) was added to each stoppered graduated test tube in turn, followed by adding 50μL of the test sample solution of different concentrations (the concentration gradient of the tea polysaccharide test solution was set to 0.05, 0.1, 0.5, 1, and 5mg / mL) and 10U / mL sucrase (dissolved in PBS buffer, pH=6) 50μL, the above mixed solution was mixed using a vortex oscillator and placed at 37.5℃ for 10min, and then 100μL of 0.5% sucrose solution (dissolved in PBS buffer, pH=6) was added and mixed and placed at 37.5℃ for 10min. After the reaction is completed, add 200 μL DNS solution and react in a boiling water bath for 5 minutes, then quickly place in cold water and cool to room temperature to terminate the reaction. After oscillation, use a UV spectrophotometer to measure the absorbance, use PBS buffer as a blank, and measure the OD value at 540 nm after dilution. Finally, calculate the sample's inhibition rate of sucrase according to the following formula:

[0059] I(%)={[(Ac-Ab)-(As-Asb)] / (Ac-Ab)}×100%

[0060] 5) Construction of hyperglycemia animal model

[0061] Ninety 4-week-old specific pathogen free (SPF) C57BL / 6J mice were purchased and randomly divided into 9 groups (10 mice in each group) after one week of adaptive feeding: normal group (NC), model group (MC), positive drug metformin hydrochloride group (DMBG) (200 mg / kg BW), TWE group (Tea water extracts (TWE)) (400 mg / kg BW), TPS group (400 mg / kg BW), TP group (400 mg / kg BW), and three different ratios of p4 M-TPS-TP compound groups (p4 M-TPS:TP=2:1, 1:1 and 1:2, 400 mg / kg BW). Afterwards, except for the NC group mice fed with ordinary feed, the other mice were fed with high sugar and high fat feed for a total of six weeks. On the first day of the eighth week: After all mice were fasted for 12 hours in advance but not water-free, the NC group mice were intraperitoneally injected with 0.1 mol / L citric acid-sodium citrate buffer (pH = 4.5), and the other groups were injected with 50 mmol / L streptozotocin solution at a dose of 50 mg / kg, once every other day, for a total of three times. One week after the streptozotocin injection, the fasting blood glucose (FBG) of the modeling mice was tested. If FBG ≥ 11.0 mmol / L and there were symptoms of "three more and one less", and the blood glucose value was statistically different from that of the NC group, the hyperglycemia model was considered to be successfully established.

[0062] After modeling, the model mice were redivided into 9 groups (normal group (NC), model group (MC), positive drug metformin hydrochloride group (DMBG) (200 mg / kg BW), TWE group (400 mg / kg BW), TPS group (400 mg / kg BW), TP group (400 mg / kg BW), and three different ratios of p4 M-TPS-TP compound groups (p4 M-TPS:TP = 2:1, 1:1 and 1:2, 400 mg / kg BW)) and marked. After that, all groups were fed with water + ordinary feed. The NC and MC groups were fed normally without treatment, and each sample intervention group was intervened by gavage according to the dose. After 6 weeks of feeding, blood samples were collected from mice by orbital venous plexus blood collection method. The blood samples were centrifuged at 4000 rpm for 5 minutes at 4°C to separate serum. Then, the mice were euthanized by isoflurane anesthesia and cervical dislocation, and tissues were collected immediately.

[0063] 6) Measurement of body weight and blood sugar indexes

[0064] During the intervention period, the body weight (BW) and fasting blood glucose (FBG) values ​​of the experimental mice were regularly measured and recorded. Before FBG measurement, all mice were fasted for 12 hours in advance but not water, and then the blood glucose value was measured by tail cutting and blood sampling.

[0065] 7) Oral glucose tolerance test and insulin tolerance test

[0066] In the last two weeks of the experiment, oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed on the experimental mice.

[0067] The mice were fasted for 15 hours in advance but water was not allowed. Then the BG level in the tail vein of the mice was measured as the initial blood glucose (0 min). All mice were then gavaged with 2 g / kg glucose solution, and their BG values ​​were measured at 15, 30, 60, 90 and 120 min for OGTT determination.

[0068] The mice were fasted for 4 hours in advance but water was not allowed. The BG level in the tail vein of the mice was measured as the BG value of the initial test 0min. Then all mice were intraperitoneally injected with insulin solution (0.75U / kg, prepared with acidic saline) for ITT measurement. Blood samples were collected at 15, 30, 45, and 60min after injection, and the BG value was recorded.

[0069] 8) Serum biochemical index detection

[0070] The corresponding ELISA kits were used to detect total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in serum.

[0071] 9) Tissue section analysis

[0072] Colon tissue was immersed in neutral formaldehyde, dehydrated, paraffin-embedded, sliced, baked, stained, and then pathological analysis of tissue sections was performed.

[0073] 10) Determination of key protein expression in the TGR5 / GLP-1 pathway

[0074] Detection of key protein expression in the TGR5 / GLP-1 pathway in pancreatic and colonic tissues: Proteins were extracted from the tissues, and then the protein concentration was quantified using a bi-creatinine (BCA) kit. The samples were transferred to a PVDF membrane (280 mA, 1 kda / min) after electrophoresis (80 V, 0.5 h and 120 V, 1 h). The strips were placed in the blocking buffer for 1 h, then incubated with the primary antibody for 16 h and the secondary antibody for 30 min. After washing, the strips were sent for exposure, and after image acquisition, the optical density value of the target strips was analyzed using a software processing system, and grayscale analysis was performed to complete the determination of TGR5, cAMP, PKA, CREB, PC1 / 3, and GLP-1 proteins in the pancreatic and colonic tissues of the experimental group mice.

[0075] The results of the above analysis and testing are as follows:

[0076] 1) Inhibitory effects of different combinations of tea cell wall polysaccharides and tea polyphenols on enzymes related to sugar metabolism

[0077] Digestive enzymes such as α-glucosidase, α-amylase and sucrase play a key role in the breakdown of carbohydrates in the digestive system and regulate blood sugar levels. Specifically, α-glucosidase and sucrase are mainly located on intestinal mucosal cells, while α-amylase is mainly found in the mouth and pancreas. In order to determine the optimal ratio for hypoglycemic effect in vitro, the inhibitory activity of five different ratios of p4M-TPS / TP combinations on enzymes related to sugar metabolism was evaluated. The results showed that these combinations had significant inhibitory effects on α-glucosidase, α-amylase and sucrase, and within a certain range, the higher the concentration of the combination, the stronger the inhibitory effect on the activity of these enzymes.

[0078] like Figure 2 As shown in A, all five combinations showed inhibitory effects on α-glucosidase, but there were significant differences in the inhibitory activities of the combinations with different ratios (p<0.05). It is worth noting that p4M-TPS / TP showed higher inhibitory activities at the ratios of 1:1, 1:2, and 2:1, with IC values ​​of 0.05 for α-glucosidase. 50 The values ​​were 6.970, 6.493 and 5.673 μg / mL respectively. 1:2 IC 50 On the contrary, when the ratio is 1:3 and 3:1, the inhibitory ability of the combination on the enzyme is relatively weak, and the IC 50 The values ​​were 32.562 and 53.701 μg / mL respectively. Figure 2As shown in Figure B, at concentrations below 0.5 mg / mL, the inhibition of α-amylase was relatively mild, but significant differences in inhibitory activity were observed at higher concentrations. Specifically, when the ratio of p4M-TPS / TP was 1:1, 1:2, and 2:1, the composition showed strong inhibition, with an IC of 0.1% against α-amylase. 50 The values ​​were 2.934, 4.458 and 5.057 mg / mL respectively. 1:1 The inhibitory activity against α-amylase is the strongest. Figure 2 As shown in Figure C, there is no significant difference in the inhibitory activity of different ratios of the combination on sucrase. Similarly, when the ratio of p4M-TPS / TP is 1:1, 1:2 and 2:1, the inhibitory effect of the combination is obvious, and the IC 50 The values ​​were 4.003, 2.029 and 2.692 mg / mL, respectively. 1:2 The inhibitory activity against sucrase was the strongest.

[0079] Table 1 shows that after purification, the inhibitory activity of 4M-TPS on α-glucosidase decreased, which may be due to the removal of polyphenols in p4M-TPS, while it had no inhibitory activity on α-amylase and sucrase. In contrast, TP showed significant inhibitory activity on all three enzymes, while TWE had stronger inhibitory activity on α-glucosidase than these compounds, but weaker inhibitory activity on α-amylase and sucrase than these compositions. It is worth noting that even at high concentrations, the inhibition rate of TWE did not reach 50%, indicating that the composition may have a better hypoglycemic effect. In summary, the combination of tea polysaccharides and tea polyphenols has stronger inhibitory activity on enzymes related to sugar metabolism than any single component. When the ratio of p4M-TPS / TP was 1:1, 1:2 and 2:1, the inhibitory effect of the composition was obvious, although there was no significant difference in the inhibitory effect of the three compositions (p>0.05). Therefore, p4M-TPS / TP with a ratio of 1:1, 1:2 and 2:1 was selected for subsequent studies.

[0080] Table 1 Inhibitory activity of sugar metabolism enzymes by tea cell wall polysaccharides and tea polyphenols in different proportions

[0081]

[0082]

[0083] Note: Different superscript letters represent significant differences among the groups (p<0.05), and each column was analyzed for significant differences within the group.

[0084] 2) Physiological indicators of hyperglycemic mice

[0085] like Figure 3As shown in A, after 6 weeks, except for p4M-TPS / TP 1:2 Except for the TWE group and the DMBG group, the weight of mice in the other intervention groups and the normal group increased significantly (p<0.05). Among the intervention groups, the weight gain of mice in the TWE group was the most obvious ( Figure 3 B) It is worth noting that under normal dietary conditions, the weight of mice in the NC group increased significantly, while the weight of mice in the MC group continued to decrease and was significantly reduced. Figure 3 C and D, the fasting blood glucose levels of mice in the sixth week were compared with the initial levels. The blood glucose levels of all intervention groups were significantly reduced after 6 weeks of intervention (p < 0.01), but there was no significant difference in the amount of blood glucose reduction between the intervention groups (p > 0.05). 1:2 and p4M-TPS-TP 1:1 The best hypoglycemic effect was achieved by taking DMBG, which decreased by 39.50% and 35.54% after 6 weeks, and the average weekly blood sugar reduction was 0.78mmol / L and 0.71mmol / L, respectively. In addition, the blood sugar of mice in the NC group remained within the normal range, while the blood sugar of mice in the MC group increased by 2.3mmol / L compared with the initial level. In contrast, the fasting blood sugar of mice in the positive control group was significantly reduced after taking DMBG (△FBG=6.3mmol / L) (p<0.001).

[0086] 3) Glucose tolerance and insulin tolerance in hyperglycemic mice

[0087] like Figure 3 As shown in E, the blood glucose level of mice in the normal control group (NC group) reached a peak 30 minutes after oral gavage with glucose, then gradually decreased to normal levels, and was close to the baseline value at 120 minutes. In contrast, due to the slow regulation of blood glucose metabolism, the blood glucose levels of mice in the model control group (MC group) and the intervention group remained at a high level 120 minutes after oral gavage. However, compared with the MC group, the hyperglycemic mice in the intervention group showed significantly improved glucose metabolism regulation ability. Figure 3 As shown in Figure G, after intraperitoneal injection of insulin, the blood glucose level of mice in the NC group dropped to the range of 5.8-7.2mmol / L, indicating that mice in the NC group have a strong ability to regulate blood glucose. Similarly, the blood glucose fluctuations of mice in the DMBG group were small after insulin injection, and they dropped rapidly within 30 minutes, and then slowly dropped, indicating that this group of mice had a strong ability to regulate blood glucose. In contrast, the blood glucose levels of mice in the MC group and the intervention group also dropped rapidly after insulin injection, and the slope of the curve was steeper than that of the DMBG group. Among them, the blood glucose of mice in the intervention group dropped rapidly within 30 minutes after insulin gavage, and then remained stable or slowly increased, and did not reach the normal blood glucose range. However, the blood glucose of mice in the MC group only showed a slow upward trend 45 minutes after insulin gavage, and the blood glucose level was significantly higher than that of the intervention group, suggesting that the intervention has a restorative effect on the function of pancreatic islet β cells in hyperglycemic mice.

[0088] The area under the curve (AUC) of the oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) can be used to evaluate the degree of hyperglycemia and pancreatic islet damage in mice, reflecting the improvement of blood glucose regulation ability and pancreatic β-cell function in mice under different interventions. Figure 3 F and H show that in different intervention groups, p4M-TPS-TP 1:2 According to AUC OGTT It showed the strongest blood sugar regulation ability and had a significant improvement on glucose metabolism in hyperglycemic mice compared with other intervention groups (p<0.05). ITT , except p4M-TPS and p4M-TPS-TP 2:1 In addition, all intervention groups had a very significant improvement on the pancreatic β-cell function of hyperglycemic mice (p<0.001). 1:1 and p4M-TPS-TP 1:2 The best effect was found on the improvement of pancreatic β-cell function, indicating that p4M-TPS and TP have synergistic effects in enhancing the blood glucose regulation ability and pancreatic β-cell function in hyperglycemic mice. Similarly, compared with the dietary fiber without polyphenols and polyphenols groups, the dietary fiber containing polyphenols extracted from tea residues performed better in improving fasting blood glucose (FBG), insulin resistance index (HOMA-IR), and serum oxidative stress in rats with type 2 diabetes (T2DM).

[0089] 4) Serum biochemical indicators

[0090] Diabetic patients are often accompanied by lipid metabolism disorders, and changes in blood lipid levels are indicators of lipid metabolism. Therefore, managing blood lipid levels is as important as controlling blood sugar. Compared with the normal control group (NC group), the total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels of mice in the model control group (MC group) were significantly increased (p<0.001), while the high-density lipoprotein cholesterol (HDL-C) level was significantly decreased (p<0.001), indicating that lipid metabolism in diabetic (DM) mice was disordered. Figure 3 As shown in I, after administration of DMBG and tea active ingredients, the TC level in the intervention group was significantly lower than that in the MC group (p<0.001). 1:2 and p4M-TPS-TP 2:1 There was a significant difference in TC levels between the two groups (p<0.05), but there was no significant difference in other groups (p>0.05). 1:2 , TP and p4M-TPS showed significant improvement effects, with TC levels reduced by 32.62%, 27.90% and 24.90%, respectively.

[0091] Similarly, the levels of TG and LDL-C in the intervention group were significantly lower than those in the MC group (p<0.001). Except for the p4M-TPS group, there were no significant differences in TG levels among the other groups (p>0.05). 1:2 、p4M-TPS-TP 1:1 and TWE showed superior relief effects, with TG levels reduced by 47.02%, 45.03%, and 43.05%, respectively ( Figure 3 J). There was no significant difference in LDL-C levels between the intervention groups (p>0.05). 1:1 、p4M-TPS-TP 1:2 The lowering effects of TWE and LDL-C were more significant, with LDL-C levels reduced by 34.55%, 33.94% and 32.12% respectively ( Figure 3 K) For HDL-C levels, except for p4M-TPS-TP 1:2 and p4M-TPS-TP 2:1 Except for the MC group, all other groups showed significant increases (p<0.001), but there were no significant differences between the groups (p>0.05). 1:2 , TWE and TP showed more significant effects in improving the HDL-C level of DM mice, increasing by 69.44%, 59.26% and 56.48%, respectively ( Figure 3 L). Therefore, all intervention groups effectively improved lipid metabolism disorders in DM mice, among which p4M-TPS-TP 1:2 The polysaccharide showed the strongest effect. It can reduce the concentration of TG, TC and LDL-C in serum, increase the concentration of HDL-C, and improve lipid metabolism disorders.

[0092] 5) Histopathological analysis

[0093] like Figure 4 As shown in the figure, the colon tissue structure of mice in the normal group (NC group) was generally normal, with relatively orderly arrangement of epithelial cells in the tissue mucosa, no mucosal epithelial cell shedding or necrosis, a large number of goblet cells in the mucosal layer, a dense lamina propria, and no obvious inflammatory cell infiltration in the tissue. In contrast, the colon mucosal epithelial cells of mice in the model group (MC group) showed degeneration and necrosis, and the necrotic epithelial cells showed nuclear condensation, nuclear dissolution or nuclear fragmentation. At the same time, the interstitial fibrous connective tissue proliferated, the basement membrane was damaged, and there was obvious inflammatory infiltration in the tissue. After administration of p4M-TPS-TP 1:2After intervention with TP, the arrangement of mucosal epithelial cells in the colon tissue of mice was relatively regular, with no mucosal epithelial cell shedding or necrosis, and no inflammatory cell infiltration in the tissue. However, the submucosal layer of the colon tissue of mice in the p4M-TPS group showed inflammatory symptoms similar to those in the MC group, indicating that p4M-TPS-TP 1:2 and TP can improve the inflammatory symptoms of the colon in type 2 diabetic (T2DM) mice, while the intervention effect of tea polysaccharides alone is not obvious.

[0094] 6) Expression of key proteins in the TGR5 / GLP-1 pathway

[0095] TGR5 plays a key role in improving glucose and lipid metabolism and is expressed in pancreatic β cells and intestinal endocrine cells. The main mechanism of its action is that TGR5 enhances the secretion of glucagon-like peptide-1 (GLP-1) after activation. Activation of TGR5 triggers an increase in intracellular cyclic adenosine monophosphate (cAMP) levels, and cAMP is a mediator of the production of multiple hormones, among which protein kinase A (PKA) is the main effector of cAMP. TGR5 can stimulate the cAMP / PKA / CREB pathway to induce GLP-1 secretion. The increase in cAMP induced by TGR5 activates PKA, which in turn activates CREB, a downstream transcription factor of PKA. Activated CREB can bind to the cAMP response element (CRE) in the promoter region of cAMP / CREB downstream target genes through its basic leucine zipper domain, thereby activating the transcription of proglucagon (GCG). Prohormone convertase PC1 / 3 is an enzyme required for the production of GLP-1. After GCG expression, the same proglucagon is produced, and finally, with the participation of PC1 / 3, proglucagon is processed into GLP-1.

[0096] Western blotting was used to detect the expression levels of key proteins in the TGR5 / GLP-1 pathway in the pancreas and colon tissues of hyperglycemic mice. Figure 5 As shown in the figure, in the pancreas of mice, the expression levels of TGR5, cAMP, PKA, CREB, PC1 / 3, and GLP-1 in the model group (MC group) were significantly decreased compared with the normal group (NC group) (p<0.001). After intervention with tea polyphenols, tea polysaccharides, and the combination of tea polyphenols and tea polysaccharides, the protein expression levels of hyperglycemic mice were significantly increased compared with the MC group (p<0.001). In addition, compared with p4M-TPS and TP alone, p4M-TPS-TP 1:2 The p4M-TPS group showed a more significant enhancement in the expression of TGR5 / GLP-1 pathway proteins, indicating that p4M-TPS and TP have a synergistic effect in regulating the TGR5 / GLP-1 pathway in the pancreas.

[0097] like Figure 6As shown, in the colon of mice, the expression levels of all proteins in the model group (MC group) were significantly decreased compared with the normal group (NC group) (p<0.001). After intervention with various tea active ingredients, except for the expression level of PKA in the tea polysaccharide (TP) group, which was not significantly different from the MC group (p>0.05), the expression levels of TGR5, cAMP, PKA, CREB, PC1 / 3 and GLP-1 proteins in the colon of hyperglycemic mice were significantly increased (p<0.001). Consistent with the findings in the pancreas, p4M-TPS-TP 1:2 The p4M-TPS group showed superior effects than the p4M-TPS and TP groups in enhancing the expression of the TGR5 / GLP-1 pathway, indicating that p4M-TPS and TP have synergistic effects in regulating the TGR5 / GLP-1 pathway in the colon.

[0098] Glucagon-like peptide-1 (GLP-1) is a hormone that induces incretin effects and plays an important role in improving diabetic symptoms, such as enhancing glucose-stimulated insulin secretion, reducing appetite, delaying gastric emptying, and inhibiting β-cell dysfunction. It has been reported that tea polysaccharides and tea polyphenols can promote the secretion of GLP-1 in pancreatic islet cells. On this basis, this study found that p4M-TPS and TP interventions can significantly promote the secretion of GLP-1 in colon tissue, and the combination of tea polyphenols and tea polysaccharides, such as p4M-TPS-TP 1:2 , and had a synergistic effect in promoting the expression of the TGR5 / GLP-1 pathway. In summary, p4M-TPS, TP, and their combination can promote TGR5-induced GLP-1 secretion in the pancreas and colon. Compared with the MC group, p4M-TPS, TP, and p4M-TPS-TP 1:2 The expression levels of TGR5, cAMP, PKA, CREB, PC1 / 3 and GLP-1 in the group were significantly increased, and p4M-TPS-TP 1:2 It exhibited a significant synergistic effect in promoting the expression of the TGR5 / GLP-1 pathway, further enhancing the hypoglycemic activity of tea active ingredients compared with p4M-TPS or TP alone.

[0099] Example 2

[0100] This embodiment provides a dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols, wherein the dietary nutritional supplement comprises 1 part of purified green tea cell wall polysaccharides, 2 parts of tea polyphenols, 0.2-0.8 parts of stevioside C, 0.2-0.8 parts of vitamin D2, and 0.2-0.8 parts of leucine.

[0101] The method for self-assembling and compounding the purified green tea cell wall polysaccharides and tea polyphenols is as described in Example 1.

[0102] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.

Claims

1. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols, It is characterized in that The dietary supplement comprises an active ingredient; The active ingredients include purified green tea cell wall polysaccharides and tea polyphenols; In the active ingredients, the mass ratio of the purified green tea cell wall polysaccharide to tea polyphenols is 1:3 to 3:

1.

2. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 1, It is characterized in that The method for preparing the dietary supplement comprises the following steps: The purified green tea cell wall polysaccharide is self-assembled and compounded with tea polyphenols to improve the solubility of the green tea cell wall polysaccharide.

3. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 2, It is characterized in that The preparation method of the dietary supplement specifically comprises the following steps: Purified green tea cell wall polysaccharides and tea polyphenols were weighed, added into ultrapure water to dissolve and mix evenly, the mixed solution was filtered through a 0.22 μm filter membrane, and the filtrate was freeze-dried to obtain a purified green tea cell wall polysaccharide and tea polyphenols complex, named p4 M-TPS-TP.

4. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 1, It is characterized in that The dietary supplement also includes pharmaceutically acceptable excipients.

5. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 5, It is characterized in that The auxiliary material is selected from one or more of starch, dextrin, cellulose, cellulose derivatives or oligosaccharides.

6. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 1, It is characterized in that The dietary nutritional supplement comprises the following raw materials in parts by weight: 1 part of purified green tea cell wall polysaccharide, 2 parts of tea polyphenols, 0.2-0.8 parts of stevioside C, 0.2-0.8 parts of vitamin D2, and 0.2-0.8 parts of leucine.

7. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 1, It is characterized in that The dietary supplement is in the form of a tablet, capsule, granule, granule or pill.

8. A dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols according to claim 1, It is characterized in that The method for preparing the purified green tea cell wall polysaccharide comprises the following steps: Green tea is sequentially extracted with water, cyclohexanediaminetetraacetic acid, sodium carbonate and sodium hydroxide solutions of different concentrations, and then purified green tea cell wall polysaccharides are obtained through impurity removal, dialysis and freeze-drying.

9. Use of the dietary nutritional supplement for regulating sugar metabolism based on green tea cell wall polysaccharides and tea polyphenols as claimed in any one of claims 1 to 8 in the preparation of medicines or health products for regulating sugar and lipid metabolism, reducing oxidative stress, and improving inflammatory response of the body.

10. The use according to claim 9, It is characterized in that The instructions for medicines or health products state: The intake of the complex of green tea cell wall polysaccharides and tea polyphenols should be controlled at 350-450 mg / d.